SCHEMBL25979934

SCHEMBL25979934

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)oc3cc(-c5nc(-c6ccccc6)nc(-c6cccc7c6oc6ccccc67)n5)ccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
PRKDC P78527 2/20 0.38
ALDH1A1 P00352 4/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 6/20 0.36
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 3/20 0.34
LMNA P02545 3/20 0.34
KMT2A Q03164 2/20 0.34
GGPS1 O95749 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 2/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26779177 0.96 ALOX5 (0.40) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980139 0.93 ALOX5 (0.41) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL26416738 0.93 ALOX5 (0.39) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL24255827 0.92 ALOX5 (0.44) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980375 0.92 ALOX5 (0.40) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980209 0.91 ALOX5 (0.43) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL24255927 0.91 ALOX5 (0.45) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25979933 0.90 MMP12 (0.33) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25979910 0.90 AHR (0.39) ALDH1A1POLBKDM4EMAPTTSHR
SCHEMBL25645777 0.90 ALOX5 (0.49) ALOX5PRKDCALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALOX5 660/4885PRKDC 4556/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.